Aug 7 (Reuters) - Kindred Biosciences Inc
* Kindred Biosciences announces second quarter 2017 financial results
* Q2 loss per share $0.29
* Q2 earnings per share view $-0.32 — Thomson Reuters I/B/E/S
* Kindred Biosciences - for 2017 , reiterates its previous guidance for operating expenses to be in range of $30 million to $32 million, excluding items Source text for Eikon: Further company coverage:
